OMERS Administration Corp
STRO icon

OMERS Administration Corp’s Sutro Biopharma STRO Stock Holding History

OMERS Administration Corp’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,700
Closed -$217K – 1124
2026
Q1 		$217K Sell
8,700
-2,323
-21% -$42K ﹤0.01% 899
2025
Q4 		$128K Buy
11,023
+1,508
+16% +$14.3K ﹤0.01% 952
2025
Q3 		$82.6K Hold
9,515
– – ﹤0.01% 1065
2025
Q2 		$67.9K Hold
9,515
– – ﹤0.01% 824
2025
Q1 		$61.9K Hold
9,515
– – ﹤0.01% 988
2024
Q4 		$175K Sell
9,515
-9,515
-50% -$290K ﹤0.01% 884
2024
Q3 		$658K Buy
+19,030
New +$746K 0.01% 602

Other funds holding STRO

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Samsara BioCapital
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

OMERS Administration Corp's STRO Position: Q2 2026 in Review

OMERS Administration Corp sold out of Sutro Biopharma (STRO) in Q2 2026, closing a stake of 8,700 shares — an estimated $217K sold.

OMERS Administration Corp first reported a position in STRO in Q3 2024 and held it in 7 quarters. The position peaked at $658K in Q3 2024. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • OMERS Administration Corp reported no remaining Sutro Biopharma position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 8,700 Sutro Biopharma shares in Q2 2026, an estimated $217K.
  • OMERS Administration Corp first reported a position in Sutro Biopharma in Q3 2024 and held it in 7 quarters.
  • OMERS Administration Corp's Sutro Biopharma position peaked at $658K in Q3 2024.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.